SCHEMBL2723937

SCHEMBL2723937

CC(C)N1CCC(Nc2ccc(S(=O)(=O)NC(=O)c3ccccc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.63
▸ BCL2L1 Q07817 9/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30314232 1.00 BCL2 (0.63) BCL2BCL2L1
SCHEMBL2724019 0.93 BCL2 (0.60) BCL2BCL2L1
SCHEMBL29657441 0.93 BCL2 (0.60) BCL2BCL2L1
SCHEMBL29657353 0.92 BCL2 (0.64) BCL2BCL2L1
SCHEMBL29796331 0.91 BCL2 (0.61) BCL2BCL2L1
SCHEMBL2725532 0.91 BCL2 (0.65) BCL2BCL2L1
SCHEMBL29657428 0.91 BCL2 (0.65) BCL2BCL2L1
SCHEMBL29657367 0.90 BCL2 (0.65) BCL2BCL2L1
SCHEMBL29796253 0.90 BCL2 (0.58) BCL2BCL2L1
SCHEMBL29796315 0.89 BCL2 (0.64) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435432-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-04-04 — — EP claimed
WO-2010138588-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-12-02 — — WO claimed
Send feedback